Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.

Yu VL, Hansen DS, Ko WC, Sagnimeni A, Klugman KP, von Gottberg A, Goossens H, Wagener MM, Benedi VJ; International Klebseilla Study Group.

Emerg Infect Dis. 2007 Jul;13(7):986-93. doi: 10.3201/eid1307.070187.

2.

Evaluation of differential gene expression in susceptible and resistant clinical isolates of Klebsiella pneumoniae by DNA microarray analysis.

Doménech-Sánchez A, Benedí VJ, Martínez-Martínez L, Albertí S.

Clin Microbiol Infect. 2006 Sep;12(9):936-40.

3.

New method of DNA isolation from two food additives suitable for authentication in polymerase chain reaction assays.

Urdiaín M, Doménech-Sánchez A, Albertí S, Benedí VJ, Rosselló JA.

J Agric Food Chem. 2005 May 4;53(9):3345-7.

PMID:
15853370
4.

Identification of two additives, locust bean gum (E-410) and guar gum (E-412), in food products by DNA-based methods.

Urdiain M, Doménech-Sánchez A, Albertí S, Benedí VJ, Rosselló JA.

Food Addit Contam. 2004 Jul;21(7):619-25.

PMID:
15370834
5.

Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.

Sahly H, Aucken H, Benedí VJ, Forestier C, Fussing V, Hansen DS, Ofek I, Podschun R, Sirot D, Tomás JM, Sandvang D, Ullmann U.

Antimicrob Agents Chemother. 2004 Sep;48(9):3477-82.

6.

A gene, uge, is essential for Klebsiella pneumoniae virulence.

Regué M, Hita B, Piqué N, Izquierdo L, Merino S, Fresno S, Benedí VJ, Tomás JM.

Infect Immun. 2004 Jan;72(1):54-61.

7.

Impairment of respiratory burst in polymorphonuclear leukocytes by extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae.

Sahly H, Aucken H, Benedi VJ, Forestier C, Fussing V, Hansen DS, Ofek I, Podschun R, Sirot D, Sandvang D, Tomás JM, Ullmann U.

Eur J Clin Microbiol Infect Dis. 2004 Jan;23(1):20-6. Epub 2003 Dec 2.

PMID:
14652783
8.

Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance.

Doménech-Sánchez A, Martínez-Martínez L, Hernández-Allés S, del Carmen Conejo M, Pascual A, Tomás JM, Albertí S, Benedí VJ.

Antimicrob Agents Chemother. 2003 Oct;47(10):3332-5.

9.

Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates.

Ribera A, Doménech-Sanchez A, Ruiz J, Benedi VJ, Jimenez de Anta MT, Vila J.

Microb Drug Resist. 2002 Winter;8(4):245-51.

PMID:
12523620
10.

Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production.

Martínez-Martínez L, Pascual A, Conejo Mdel C, García I, Joyanes P, Doménech-Sánchez A, Benedí VJ.

Antimicrob Agents Chemother. 2002 Dec;46(12):3926-32.

11.
12.

Role of the htrA gene in Klebsiella pneumoniae virulence.

Cortés G, de Astorza B, Benedí VJ, Albertí S.

Infect Immun. 2002 Sep;70(9):4772-6.

13.

Molecular epidemiological typing of Enterobacter cloacae isolates from a neonatal intensive care unit: three-year prospective study.

Fernández-Baca V, Ballesteros F, Hervás JA, Villalón P, Domínguez MA, Benedí VJ, Albertí S.

J Hosp Infect. 2001 Nov;49(3):173-82.

PMID:
11716634
14.

Increase of Enterobacter in neonatal sepsis: a twenty-two-year study.

Hervas JA, Ballesteros F, Alomar A, Gil J, Benedi VJ, Alberti S.

Pediatr Infect Dis J. 2001 Feb;20(2):134-40.

PMID:
11224829
15.

Activity of nine antimicrobial agents against clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and deficient or not in porins.

Doménech-Sánchez A, Pascual A, Suárez AI, Alvarez D, Benedí VJ, Martínez-Martínez L.

J Antimicrob Chemother. 2000 Nov;46(5):858-9. No abstract available.

PMID:
11062221
16.

Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles.

Martínez-Martínez L, Conejo MC, Pascual A, Hernández-Allés S, Ballesta S, Ramírez De Arellano-Ramos E, Benedí VJ, Perea EJ.

Antimicrob Agents Chemother. 2000 Sep;44(9):2534-6.

17.

Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae.

Hernández-Allés S, Conejo Md, Pascual A, Tomás JM, Benedí VJ, Martínez-Martínez L.

J Antimicrob Chemother. 2000 Aug;46(2):273-7.

PMID:
10933652
18.

Cloning, sequencing, and role in serum susceptibility of porin II from mesophilic Aeromonas hydrophila.

Nogueras MM, Merino S, Aguilar A, Benedi VJ, Tomás JM.

Infect Immun. 2000 Apr;68(4):1849-54.

19.
20.

Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.

Martínez-Martínez L, Pascual A, Hernández-Allés S, Alvarez-Díaz D, Suárez AI, Tran J, Benedí VJ, Jacoby GA.

Antimicrob Agents Chemother. 1999 Jul;43(7):1669-73.

21.

Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance.

Doménech-Sánchez A, Hernández-Allés S, Martínez-Martínez L, Benedí VJ, Albertí S.

J Bacteriol. 1999 May;181(9):2726-32.

22.

Porin expression in clinical isolates of Klebsiella pneumoniae.

Hernández-Allés S, Albertí S, Alvarez D, Doménech-Sánchez A, Martínez-Martínez L, Gil J, Tomás JM, Benedí VJ.

Microbiology. 1999 Mar;145 ( Pt 3):673-9.

PMID:
10217501
23.

Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes.

Hernández-Allés S, Benedí VJ, Martínez-Martínez L, Pascual A, Aguilar A, Tomás JM, Albertí S.

Antimicrob Agents Chemother. 1999 Apr;43(4):937-9.

24.

Klebsiella pneumoniae lipopolysaccharide O typing: revision of prototype strains and O-group distribution among clinical isolates from different sources and countries.

Hansen DS, Mestre F, Alberti S, Hernández-Allés S, Alvarez D, Doménech-Sánchez A, Gil J, Merino S, Tomás JM, Benedí VJ.

J Clin Microbiol. 1999 Jan;37(1):56-62.

25.

Activation of the complement classical pathway (C1q binding) by mesophilic Aeromonas hydrophila outer membrane protein.

Merino S, Nogueras MM, Aguilar A, Rubires X, Albertí S, Benedí VJ, Tomás JM.

Infect Immun. 1998 Aug;66(8):3825-31.

26.

Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains.

Martínez-Martínez L, García I, Ballesta S, Benedí VJ, Hernández-Allés S, Pascual A.

Antimicrob Agents Chemother. 1998 Jul;42(7):1850-2. Erratum in: Antimicrob Agents Chemother 1998 Oct;42(10):2772.

27.

Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.

Ardanuy C, Liñares J, Domínguez MA, Hernández-Allés S, Benedí VJ, Martínez-Martínez L.

Antimicrob Agents Chemother. 1998 Jul;42(7):1636-40.

28.

Mesophilic Aeromonas sp. serogroup O:11 resistance to complement-mediated killing.

Merino S, Rubires X, Aguilar A, Albertí S, Hernandez-Allés S, Benedí VJ, Tomas JM.

Infect Immun. 1996 Dec;64(12):5302-9.

29.

Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae.

Albertí S, Alvarez D, Merino S, Casado MT, Vivanco F, Tomás JM, Benedí VJ.

Infect Immun. 1996 Nov;64(11):4726-32.

30.

Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36.

Albertí S, Marqués G, Hernández-Allés S, Rubires X, Tomás JM, Vivanco F, Benedí VJ.

Infect Immun. 1996 Nov;64(11):4719-25.

31.

In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.

Martínez-Martínez L, Hernández-Allés S, Albertí S, Tomás JM, Benedi VJ, Jacoby GA.

Antimicrob Agents Chemother. 1996 Feb;40(2):342-8.

32.

Salicylate-enhanced exposure of Klebsiella pneumoniae subcapsular components.

Salo RJ, Domenico P, Tomás JM, Straus DC, Merino S, Benedí VJ, Cunha BA.

Infection. 1995 Nov-Dec;23(6):371-7.

PMID:
8655209
33.

A porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding.

Albertí S, Rodríquez-Quiñones F, Schirmer T, Rummel G, Tomás JM, Rosenbusch JP, Benedí VJ.

Infect Immun. 1995 Mar;63(3):903-10.

34.

A novel plasmid series for in vitro production of phoA translational fusions and its use in the construction of Escherichia coli PhoE::PhoA hybrid proteins.

Rodríguez-Quiñones F, Hernández-Allés S, Albertí S, Escribá PV, Benedí VJ.

Gene. 1994 Dec 30;151(1-2):125-30.

PMID:
7828860
35.

Neonatal sepsis caused by a new group B streptococcal serotype (type V)

Hervás JA, Benedí VJ.

J Pediatr. 1993 Nov;123(5):839. No abstract available.

PMID:
8229503
36.

The role of the O-antigen lipopolysaccharide and capsule on an experimental Klebsiella pneumoniae infection of the rat urinary tract.

Camprubí S, Merino S, Benedí VJ, Tomás JM.

FEMS Microbiol Lett. 1993 Jul 15;111(1):9-13.

PMID:
7689524
37.

Neonatal sepsis and meningitis in Mallorca, Spain, 1977-1991.

Hervás JA, Alomar A, Salvá F, Reina J, Benedí VJ.

Clin Infect Dis. 1993 May;16(5):719-24.

PMID:
8507765
38.

Development of an enzyme-linked immunosorbent assay method for typing and quantitation of Klebsiella pneumoniae lipopolysaccharide: application to serotype O1.

Albertí S, Hernández-Allés S, Gil J, Reina J, Martínez-Beltrán J, Camprubí S, Tomás JM, Benedí VJ.

J Clin Microbiol. 1993 May;31(5):1379-81.

39.

Neonatal group B streptococcal infection in Mallorca, Spain.

Hervás JA, González L, Gil J, Paoletti LC, Madoff LC, Benedí VJ.

Clin Infect Dis. 1993 May;16(5):714-8.

PMID:
8099503
40.

C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins.

Albertí S, Marqués G, Camprubí S, Merino S, Tomás JM, Vivanco F, Benedí VJ.

Infect Immun. 1993 Mar;61(3):852-60.

41.

Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing.

Merino S, Camprubí S, Albertí S, Benedí VJ, Tomás JM.

Infect Immun. 1992 Jun;60(6):2529-35.

42.

[Molecular bases for the serotypes of group B streptococci].

Benedí VJ, Hervás JA.

Enferm Infecc Microbiol Clin. 1992 Jun-Jul;10(6):321-2. Spanish. No abstract available.

PMID:
1391012
43.

Isolation and characterization of bacteriophage FC3-10 from Klebsiella spp.

Camprubí S, Merino S, Benedí VJ, Tomás JM.

FEMS Microbiol Lett. 1991 Oct 15;67(3):291-7.

PMID:
1769536
44.

Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide.

Wessels MR, DiFabio JL, Benedì VJ, Kasper DL, Michon F, Brisson JR, Jelínková J, Jennings HJ.

J Biol Chem. 1991 Apr 15;266(11):6714-9.

45.

Influence of environmental conditions on infection of Klebsiella pneumoniae by two different types of bacteriophages.

Benedí VJ, Regué M, Albertí S, Camprubí S, Tomás JM.

Can J Microbiol. 1991 Apr;37(4):270-5.

PMID:
1913339
46.

Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.

Wessels MR, Rubens CE, Benedí VJ, Kasper DL.

Proc Natl Acad Sci U S A. 1989 Nov;86(22):8983-7.

47.

Isolation and characterization of Klebsiella pneumoniae unencapsulated mutants.

Benedí VJ, Ciurana B, Tomás JM.

J Clin Microbiol. 1989 Jan;27(1):82-7.

48.

Aeromonas hydrophila strains with moderate virulence.

Merino S, Benedí VJ, Tomás JM.

Microbios. 1989;59(240-241):165-73.

PMID:
2593869
49.

A high molecular weight lipopolysaccharide specific bacteriophage for Klebsiella pneumoniae.

Benedí VJ, Ciurana B, Tomás JM.

Can J Microbiol. 1988 Jul;34(7):918-21.

PMID:
3058277
50.

Role of lipopolysaccharide and complement in susceptibility of Escherichia coli and Salmonella typhimurium to non-immune serum.

Tomás JM, Ciurana B, Benedí VJ, Juarez A.

J Gen Microbiol. 1988 Apr;134(4):1009-16.

PMID:
3053980

Supplemental Content

Loading ...
Support Center